Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3‐month observational, longitudinal, cohort, multicenter, Italian real‐life study
出版年份 2021 全文链接
标题
Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3‐month observational, longitudinal, cohort, multicenter, Italian real‐life study
作者
关键词
-
出版物
EUROPEAN JOURNAL OF NEUROLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2021-11-26
DOI
10.1111/ene.15197
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Headache characteristics and burden from chronic migraine with medication overuse headache: Cross‐sectional observations from the Medication Overuse Treatment Strategy trial
- (2021) Todd J. Schwedt et al. HEADACHE
- Association between response to triptans and response to erenumab: real-life data
- (2021) Ilaria Frattale et al. JOURNAL OF HEADACHE AND PAIN
- Cost-Effectiveness of Erenumab for the Preventive Treatment of Migraine in Patients with Prior Treatment Failures in Sweden
- (2021) Ronan Mahon et al. PHARMACOECONOMICS
- Pathophysiological Bases of Comorbidity in Migraine
- (2021) Claudia Altamura et al. Frontiers in Human Neuroscience
- A link between gastrointestinal disorders and migraine: Insights into the gut–brain connection
- (2021) Sheena K. Aurora et al. HEADACHE
- Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)
- (2021) Fabrizio Vernieri et al. JOURNAL OF HEADACHE AND PAIN
- Migraine: epidemiology and systems of care
- (2021) Messoud Ashina et al. LANCET
- Clinical features, disease progression, and use of healthcare resources in a large sample of 866 patients from 24 headache centers: A real‐life perspective from the Italian chROnic migraiNe (IRON) project
- (2021) Piero Barbanti et al. HEADACHE
- When should we consider chronic patients as non-responders to monoclonal antibodies targeting the CGRP pathway?
- (2021) Claudia Altamura et al. JOURNAL OF NEUROLOGY
- Efficacy and safety of eptinezumab in patients with chronic migraine
- (2020) Richard B. Lipton et al. NEUROLOGY
- Dopaminergic symptoms in migraine: A cross-sectional study on 1148 consecutive headache center-based patients
- (2020) Piero Barbanti et al. CEPHALALGIA
- Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans
- (2020) Tessa de Vries et al. PHARMACOLOGY & THERAPEUTICS
- Conversion from chronic to episodic migraine in patients treated with erenumab: real-life data from an Italian region
- (2020) Raffaele Ornello et al. JOURNAL OF HEADACHE AND PAIN
- Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial
- (2020) Wim M Mulleners et al. LANCET NEUROLOGY
- Erenumab in the prevention of high‐frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real‐life study
- (2020) Piero Barbanti et al. HEADACHE
- European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
- (2019) Simona Sacco et al. JOURNAL OF HEADACHE AND PAIN
- Life With Migraine: Effects on Relationships, Career, and Finances From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
- (2019) Dawn C. Buse et al. HEADACHE
- Content Validity of HIT‐6 as a Measure of Headache Impact in People With Migraine: A Narrative Review
- (2019) Carrie R. Houts et al. HEADACHE
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
- (2018) CEPHALALGIA
- CGRP as the target of new migraine therapies — successful translation from bench to clinic
- (2018) Lars Edvinsson et al. Nature Reviews Neurology
- Preventive effects of galcanezumab in adult patients with episodic or chronic migraine are persistent: data from the phase 3, randomized, double-blind, placebo-controlled EVOLVE-1, EVOLVE-2, and REGAIN studies
- (2018) Stefanie Förderreuther et al. JOURNAL OF HEADACHE AND PAIN
- Galcanezumab in chronic migraine
- (2018) Holland C. Detke et al. NEUROLOGY
- Patient satisfaction, health care resource utilization, and acute headache medication use with galcanezumab: results from a 12-month open-label study in patients with migraine
- (2018) Janet H Ford et al. Patient Preference and Adherence
- Superficial Esophageal Mucosal Afferent Nerves May Contribute to Reflux Hypersensitivity in Nonerosive Reflux Disease
- (2017) Philip Woodland et al. GASTROENTEROLOGY
- Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design
- (2017) Daniel Serrano et al. JOURNAL OF HEADACHE AND PAIN
- Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
- (2017) Stewart Tepper et al. LANCET NEUROLOGY
- Fremanezumab for the Preventive Treatment of Chronic Migraine
- (2017) Stephen D. Silberstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis
- (2016) Zsolt Hepp et al. CEPHALALGIA
- Chronic Migraine: An Update on Physiology, Imaging, and the Mechanism of Action of Two Available Pharmacologic Therapies
- (2016) Sheena K. Aurora et al. HEADACHE
- The pharmacogenomics of epilepsy
- (2015) Valentina Franco et al. Expert Review of Neurotherapeutics
- The pharmacogenomics of epilepsy
- (2015) Valentina Franco et al. Expert Review of Neurotherapeutics
- Pharmacological Trials in Migraine: It's Time to Reappraise Where the Headache Is and What the Pain Is Like
- (2014) Piero Barbanti et al. HEADACHE
- Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results From the American Migraine Prevalence and Prevention Study
- (2012) Dawn C. Buse et al. HEADACHE
- Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial
- (2012) Piero Barbanti et al. JOURNAL OF HEADACHE AND PAIN
- Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Table 1
- (2012) S.D. Silberstein et al. NEUROLOGY
- Calcitonin gene-related peptide: A molecular link between obesity and migraine?
- (2010) A. Recober et al. DRUG NEWS & PERSPECTIVES
- OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program
- (2010) David W. Dodick et al. HEADACHE
- EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force
- (2009) S. Evers et al. EUROPEAN JOURNAL OF NEUROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now